Drug target · GRIN1
NMDA receptor
N-methyl-D-aspartate (NMDA) glutamate receptor
5 compounds in the CNS pipeline act on NMDA receptor.
Compounds targeting NMDA receptor
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| AXS-05 (dextromethorphan-bupropion)primarySmall molecule | Antagonist | — | Phase 2Tobacco use disorder | Axsome Therapeutics, Inc. |
| Blixeprodil (GM-1020)primarySmall molecule | Antagonist | Ki 3.25 µM | Phase 2Major depressive disorder | Gilgamesh Pharmaceuticals, Inc. |
| AVP-786 (deudextromethorphan-quinidine)primarySmall molecule | Antagonist | — | DiscontinuedAgitation in Alzheimer's disease | Avanir Pharmaceuticals |
| DalzanemdorprimarySmall molecule | PAM | — | DiscontinuedHuntington's disease | Sage Therapeutics, Inc. |
| Esmethadone (REL-1017)Small molecule | Antagonist | — | DiscontinuedMajor depressive disorder | Relmada Therapeutics, Inc. |